{"id":"https://openalex.org/W4387543660","doi":"https://doi.org/10.1159/000532100","title":"Pembrolizumab-Induced Rhabdomyolysis in a Clear Cell Renal Cell Carcinoma Patient: A Case Report","display_name":"Pembrolizumab-Induced Rhabdomyolysis in a Clear Cell Renal Cell Carcinoma Patient: A Case Report","publication_year":2023,"publication_date":"2023-08-25","ids":{"openalex":"https://openalex.org/W4387543660","doi":"https://doi.org/10.1159/000532100"},"language":"en","primary_location":{"id":"doi:10.1159/000532100","doi":"https://doi.org/10.1159/000532100","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000532100","pdf_url":null,"source":{"id":"https://openalex.org/S62365728","display_name":"Case Reports in Oncology","issn_l":"1662-6575","issn":["1662-6575"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Reports in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1159/000532100","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023065145","display_name":"Mohammad Altermanini","orcid":"https://orcid.org/0000-0001-6756-6023","observed_orcids":["https://orcid.org/0000-0001-6756-6023"]},"institutions":[{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Mohammad Altermanini","raw_affiliation_strings":["Internal Medicine, Hamad Medical Corporation, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Hamad Medical Corporation, Doha, Qatar","institution_ids":["https://openalex.org/I49828101"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Khaled Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":true,"raw_author_name":"Khaled Ali","raw_affiliation_strings":["Community Medicine, Hamad Medical Corporation, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Community Medicine, Hamad Medical Corporation, Doha, Qatar","institution_ids":["https://openalex.org/I49828101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026814280","display_name":"Wisam Alwassiti","orcid":"https://orcid.org/0009-0000-9502-4010","observed_orcids":["https://orcid.org/0009-0000-9502-4010"]},"institutions":[{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Wisam Alwassiti","raw_affiliation_strings":["Internal Medicine, Hamad Medical Corporation, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Hamad Medical Corporation, Doha, Qatar","institution_ids":["https://openalex.org/I49828101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093045734","display_name":"Suliman Almohtasib","orcid":"https://orcid.org/0000-0003-0707-2990","observed_orcids":["https://orcid.org/0000-0003-0707-2990"]},"institutions":[{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Suliman Almohtasib","raw_affiliation_strings":["Hamad Medical Corporation, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hamad Medical Corporation, Doha, Qatar","institution_ids":["https://openalex.org/I49828101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014291563","display_name":"Nabil Elhadi Omar","orcid":"https://orcid.org/0000-0001-8291-7987","observed_orcids":["https://orcid.org/0000-0001-8291-7987"]},"institutions":[{"id":"https://openalex.org/I4210118835","display_name":"National Center for Cancer Care and Research","ror":"https://ror.org/02d4f9f51","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210118835","https://openalex.org/I49828101"]},{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]},{"id":"https://openalex.org/I60342839","display_name":"Qatar University","ror":"https://ror.org/00yhnba62","country_code":"QA","type":"education","lineage":["https://openalex.org/I60342839"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Nabil E. Omar","raw_affiliation_strings":["PhD. Candidate, Health Sciences Program, Clinical and Population Health Research, College of Pharmacy, Qatar University, Doha, Qatar","Pharmacy Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PhD. Candidate, Health Sciences Program, Clinical and Population Health Research, College of Pharmacy, Qatar University, Doha, Qatar","institution_ids":["https://openalex.org/I60342839"]},{"raw_affiliation_string":"Pharmacy Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar","institution_ids":["https://openalex.org/I4210118835","https://openalex.org/I49828101"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104065012","display_name":"Abdulaziz Zafar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Abdulaziz Zafar","raw_affiliation_strings":["Internal Medicine, Hamad Medical Corporation, Doha, Qatar"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Hamad Medical Corporation, Doha, Qatar","institution_ids":["https://openalex.org/I49828101"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I49828101"],"apc_list":{"value":1170,"currency":"USD","value_usd":1170},"apc_paid":{"value":1170,"currency":"USD","value_usd":1170},"fwci":0.2532,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.52867142,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"16","issue":"1","first_page":"728","last_page":"733"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9365000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9365000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12117","display_name":"Muscle and Compartmental Disorders","score":0.029500000178813934,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/rhabdomyolysis","display_name":"rhabdomyolysis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/clear-cell-renal-cell-carcinoma","display_name":"clear cell renal cell carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9390000104904175},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9020000100135803},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.9919999837875366},{"id":"https://openalex.org/keywords/hypothyroidism","display_name":"hypothyroidism","score":0.9919999837875366}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.9703546762466431},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9311753511428833},{"id":"https://openalex.org/C2779379848","wikidata":"https://www.wikidata.org/wiki/Q917069","display_name":"Rhabdomyolysis","level":2,"score":0.8717153072357178},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.7400342226028442},{"id":"https://openalex.org/C2781068499","wikidata":"https://www.wikidata.org/wiki/Q3242950","display_name":"Kidney cancer","level":3,"score":0.5802779197692871},{"id":"https://openalex.org/C2781278892","wikidata":"https://www.wikidata.org/wiki/Q18556340","display_name":"Clear cell renal cell carcinoma","level":3,"score":0.5757985711097717},{"id":"https://openalex.org/C2780472472","wikidata":"https://www.wikidata.org/wiki/Q424337","display_name":"Acute kidney injury","level":2,"score":0.49576982855796814},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43771201372146606},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.4334900379180908},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4149256944656372},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3925551176071167},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.32367733120918274}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1159/000532100","doi":"https://doi.org/10.1159/000532100","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000532100","pdf_url":null,"source":{"id":"https://openalex.org/S62365728","display_name":"Case Reports in Oncology","issn_l":"1662-6575","issn":["1662-6575"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Reports in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:7ec248beb08c448185f96d902c6799eb","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7ec248beb08c448185f96d902c6799eb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Case Reports in Oncology, Vol 16, Iss 1, Pp 728-733 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1159/000532100","doi":"https://doi.org/10.1159/000532100","is_oa":true,"landing_page_url":"https://doi.org/10.1159/000532100","pdf_url":null,"source":{"id":"https://openalex.org/S62365728","display_name":"Case Reports in Oncology","issn_l":"1662-6575","issn":["1662-6575"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","norway-1","poland-40","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Case Reports in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1976043651","https://openalex.org/W2086799671","https://openalex.org/W2097096070","https://openalex.org/W2123355918","https://openalex.org/W2144390074","https://openalex.org/W2166662937","https://openalex.org/W2177405394","https://openalex.org/W2318508214","https://openalex.org/W2413514895","https://openalex.org/W2473218705","https://openalex.org/W2572174216","https://openalex.org/W2586675028","https://openalex.org/W2736166064","https://openalex.org/W2786816161","https://openalex.org/W2793167197","https://openalex.org/W2793595491","https://openalex.org/W2807184339","https://openalex.org/W2914696936","https://openalex.org/W2924070172","https://openalex.org/W2956028371","https://openalex.org/W2985879903","https://openalex.org/W2994312780","https://openalex.org/W3015061112","https://openalex.org/W3093345288","https://openalex.org/W3094562763","https://openalex.org/W3120897493","https://openalex.org/W3168048358","https://openalex.org/W3174077356","https://openalex.org/W3196207248","https://openalex.org/W4206342514"],"related_works":["https://openalex.org/W37900826","https://openalex.org/W4407868621","https://openalex.org/W4392585884","https://openalex.org/W4367608444","https://openalex.org/W4402089099","https://openalex.org/W4412602745","https://openalex.org/W4405860574","https://openalex.org/W3038774038","https://openalex.org/W7213327413","https://openalex.org/W4393005130"],"abstract_inverted_index":{"Pembrolizumab":[0],"is":[1],"one":[2],"of":[3,10,24,40],"the":[4,22],"approved":[5],"treatments":[6],"for":[7],"many":[8,30],"types":[9],"cancer":[11],"including":[12],"clear":[13],"cell":[14,16,26],"renal":[15,25],"carcinoma":[17],"(ccRCC).":[18],"It":[19],"has":[20,29],"improved":[21],"prognosis":[23],"carcinoma,":[27],"yet":[28],"possible":[31],"immune-related":[32],"side":[33],"effects.":[34],"We":[35],"discuss":[36],"a":[37],"rare":[38],"case":[39,50],"rhabdomyolysis":[41],"in":[42],"an":[43],"ccRCC":[44],"patient":[45],"treated":[46],"with":[47,53],"pembrolizumab.":[48,65],"The":[49],"was":[51],"complicated":[52],"acute":[54],"kidney":[55],"injury":[56],"and":[57],"severe":[58],"hypothyroidism,":[59],"which":[60],"can":[61],"be":[62],"attributed":[63],"to":[64]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2023-10-12T00:00:00"}